Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c

Eikon Therapeutics, Inc. (NASDAQ: EIKN) reported Q2 EPS of ($1.63), $1.63 worse than the analyst estimate of $0.00.

For earnings history and earnings-related data on Eikon Therapeutics, Inc. (EIKN) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Diginex reports 77% revenue rise but $31M net loss in FY2026
• Innovaro (INV) Misses Q2 EPS by 9c